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ROUTINE CHANGING OF INTRAVENOUS
ADMINISTRATION SETS DOES NOT REDUCE
COLONIZATION OR INFECTION IN CENTRAL VENOUS
CATHETERS
Claire M. Rickard, RN, BN, GradDipN (CritCare); Jeff Lipman, FFA (CritCare), FJFICM; Mary Courtney, RN, PhD;
Rosemary Siversen, RN, CertNurs, CertICU; Peter Daley, RN, BHSc, CertICU
Many patients benefit from the use of intravenous
(IV) catheters for hemodynamic monitoring, blood sam-
pling, or the administration of fluid, nutrition, and med-
ication. Unfortunately, some patients develop catheter-
related infection, which increases the duration and 
complexity of hospitalization. The highest risk group con-
sists of patients with central venous catheters (CVCs) in
the intensive care unit (ICU), where infection may entail
treatment costs of approximately $71,0001 and an associ-
ated mortality rate of 25%.2 Clinicians use many strategies
to minimize the risk of infection, including routinely
changing IV administration sets more frequently than
replacing the catheter itself. 
The practice of routinely changing IV administra-
tion sets is not evidence based. Prior to the 1970s, admin-
istration sets were used until they malfunctioned or were
not required.3 After the epidemic of catheter-related bac-
teremia that occurred during the 1970s, a 24-hour replace-
ment of administration sets and fluids was advocated4 and
almost universally implemented despite the unrelated
cause of the problem (manufacturer-contaminated
fluid).5,6
During the past three decades, researchers have
slowly challenged the premise that daily set changes are
required. Several studies have shown that prolonged use of
up to 72 hours does not increase the risk of infection.7-16 Set
changes at 96 hours have been found to be equivalent to
changes at 48 hours17,18; changes “between day 4 and day 7”
have been found to be equivalent to changes at day 319; and
changes at 24, 48, 72, 96, and 120 hours have been found to
be indistinguishable from each other.20 Surprisingly, all
studies have been based on the assumption that routine
administration set changes prevent infection; the focus had
previously been to find an “ideal” interval for replacing sets
rather than questioning the efficacy of the practice per se.
The guidelines of the Centers for Disease Control
and Prevention (CDC) advise changing administration sets
for standard infusions and for non-lipid parenteral infusions
“no more frequently than every 72 hours.”21 The exact
nature of the current practice is unknown but probably
The authors are from the Royal Brisbane Hospital, Brisbane, Australia. Ms. Rickard and Professor Courtney are also from the Queensland
University of Technology and Mr. Lipman is also from the University of Queensland, Brisbane, Australia. Ms. Rickard is also from Monash University,
Traralgon, Australia.
Address reprint requests to Claire Rickard, RN, School of Rural Health, Monash University, P.O. Box 424, Traralgon, Victoria 3844, Australia.
Supported by a grant from the Royal Brisbane Hospital Research Foundation.
The authors thank the staf f of the Department of Intensive Care, Royal Brisbane Hospital, for their support of the study. They also thank Stephen
Cox for statistical advice.
OBJECTIVE: To determine the effect of routine intra-
venous (IV) administration set changes on central venous
catheter (CVC) colonization and catheter-related bacteremia.
DESIGN: Prospective, randomized, controlled trial.
SETTING: Eighteen-bed intensive care unit (ICU) in a
large metropolitan hospital.
PARTICIPANTS: Two hundred fifty-one patients with
404 chlorhexidine gluconate and silver sulfadiazine–coated multi-
lumen CVCs.
INTERVENTIONS: CVCs inserted in the ICU and in situ
on day 4 were randomized to have their IV administration sets
changed on day 4 (n = 203) or not at all (n = 201). Use of fluid con-
tainers and blood product administration sets was limited to 24
hours. CVCs were removed when not required, infection was sus-
pected, or in place on day 7. Catheter cultures were performed on
removal by blinded laboratory staff. Catheter-related bacteremia
was diagnosed by a blinded intensivist using strict definitions. Data
were collected regarding catheter duration, site, Acute Physiology
and Chronic Health Evaluation (APACHE) II score, patient age,
diagnosis, hyperglycemia, hypoalbuminemia, immune status,
number of fluid containers and IV injections, and administration of
propofol, blood, total parenteral nutrition, or lipid infusion.
RESULTS: There were 10 colonized CVCs in the group
receiving a set change and 19 in the group not receiving one.
This difference was not statistically significant on Kaplan–Meier
survival analysis. There were 3 cases of catheter-related bac-
teremia per group. Logistic regression found that burns diagno-
sis and increased ICU stay significantly predicted colonization.
CONCLUSION: IV administration sets can be used for 7
days in patients with short-term, antiseptic-coated CVCs (Infect
Control Hosp Epidemiol 2004;25:650-655).
ABSTRACT
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varies. In a small survey of hospitals in Australia, the
United States, and Canada, the most frequently reported
duration of use was 72 hours (C. Rickard, PhD candidate,
unpublished data, June 15, 2000). This seems to suggest a
misinterpretation of the CDC guidelines to replace sets at
72 hours rather than no more frequently than every 72
hours.
Lipid, blood product, and propofol administration sets
are slightly more complicated than those used for standard
solutions. The CDC advocates changes every 24 hours for
blood product and lipid sets, but every 12 hours for propo-
fol sets. 
The current study examined the effect of routinely
changing administration sets (including total parenteral
nutrition and lipid sets) compared with leaving them
intact for the duration of catheterization on catheter colo-
nization and infection. 
METHODS 
Study Setting 
This study was conducted in an 18-bed general ICU
in a 700-bed, tertiary-care referral hospital. The physi-
cians in the ICU have sole admitting, discharge, and pre-
scribing rights. Nursing staff are registered nurses
(RNs), many with ICU qualifications. More than 1,200
patients are admitted annually for an average length of
stay of 4 days.
Study Sample
A minimum sample size of 392 was calculated prior
to the study to detect a 50% colonization difference with
80% power from a baseline audited incidence of 20% at a P
value of .05. ARROWgard Blue 3- or 4-lumen CVCs coated
with chlorhexidine gluconate and silver sulfadiazine
(Arrow International, Inc., Reading, PA) were used. For
12 months, all CVCs inserted in the ICU and in situ on day
4 (day of insertion being day 1) were enrolled. A comput-
erized random-number generator randomized each CVC
to either receive a routine set change or have the original
administration set left intact for the duration of catheteri-
zation. Individual patients could have multiple catheters in
the study (the unit of measurement was the catheter).
Catheter Care
ICU medical staff inserted CVCs using an aseptic
technique at a new skin site (without a guidewire), with
new fluids and administration sets connected. Catheters
were sutured and non-tunneled. Set changes were per-
formed on catheter-day 4 at approximately 72 hours (± 12
hours) after insertion for the group receiving a set
change. RNs in the ICU prepared administration sets and
performed set changes using an aseptic technique.
Disconnection sites were decontaminated with chlorhexi-
dine.
The administration set included all connections
between the CVC and the fluid container (ie, tubing,
burettes, extension tubing, and pressure transducers).
Fluid containers (ie, bags, bottles, and syringes) were
replaced at the administration set change and every 24
hours. Blood product administration sets were discarded
after transfusion. However, administration sets used for
parenteral nutrition, lipids, and propofol infusions were
included in the study. Administration set composition was
not static. If a new infusion was required or an infusion
was no longer needed, the system was accessed using a
non-touch technique. 
Excluding administration set changes, all other
CVC care was equal between the groups. CVCs were
accessed only by the RNs and medical staff in the ICU and
were not used to aspirate blood. Dressings (Opsite
IV3000, Smith and Nephew, Hull, United Kingdom) were
changed on day 4 and if they were soiled, were loose, or
had blood beneath them. Medical staff ordered CVC
removal routinely on day 7 or earlier if the patient died,
did not require the CVC, or was suspected to have CVC
infection. Medical staff were blinded to the study group so
that their decision to order catheter removal or blood or
other cultures was not biased.
Catheter Culture
CVCs were removed by RNs in the ICU using a
standardized aseptic technique following site decontami-
nation with chlorhexidine. The distal portion of the CVC
tip was cultured using a semiquantitative technique.22
Laboratory staff were blinded to the study group. 
Data Collection
Senior nursing staff monitored protocol adherence
and collected data on microbiology results, systemic
inflammatory response syndrome,23 patient demograph-
ics, and other potential risk factors for CVC infection. A
blinded intensivist reviewed microbiological results (ie,
cultures of catheter tip, blood, and other sites) and cases
of systemic inflammatory response syndrome using strict
definitions24 to diagnose the presence or absence of
catheter-related bacteremia. 
Definitions
Catheter colonization was defined as growth of 15
colony-forming units/mm3 or more. Catheter-related bac-
teremia was diagnosed as definite, probable (types 1 and
2 combined), possible, or absent using previously
described definitions (Table 1).24 These definitions were
developed to address the difficulties associated with the
application of the CDC surveillance definition of catheter-
related bloodstream infection (BSI) in ICU patients with
multiple concurrent disease processes, colonized sites, or
both, and unavailable or incomplete microbiological data.
The “definite” and “possible” categories used in this study
combine to equate with the CDC definition of catheter-
related BSI.
Ethical Considerations
The study was approved by the Hospital and the
University Human Research Ethics Committees. Individual
consent was waived considering the legal incompetence of
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the patients. State legislation precluded relatives from con-
sidering consent; however, relatives were notified of enroll-
ment, were provided information about the study, and
could ask questions or request their relative’s withdrawal. 
Statistical Analysis
Given the varied duration of catheterization, the pri-
mary analysis of colonization between the groups was test-
ed using the Kaplan–Meier survival curve with log-rank
test. The distribution between groups of variables consid-
ered risk factors for catheter colonization was tested to
assess for bias. Proportions were tested using chi-square.
Differences in the mean scores on continuous variables
were tested with the Student’s t test. Logistic regression
modeling was performed to analyze the influence of poten-
tially confounding variables. Analysis was performed using
SPSS software (version 10.0; SPSS, Inc., Chicago, IL).
RESULTS
Sample
Two hundred fifty-one patients with 404 CVCs were
included in the study. Of these, 157 patients each con-
tributed 1 CVC; the others had multiple catheters. There
were 203 CVCs randomized to the group receiving a set
change and 201 to the group not receiving a change.
Randomization was successful in distributing most demo-
graphic variables and risk factors for infection equally
between the two groups (Table 2). The only significant
differences between the groups were a mean 6 years in
age (P = .006) and an average of 6 intravenous injections
(P = .03). It is unlikely that these differences were clini-
cally significant. There were 24,918 hours of catheter life
in the group receiving a set change and 25,384 hours in
the group not receiving a change.
Colonization
Twenty-nine (7.1%) of the CVCs were not cultured
due to autopsy or lost or contaminated specimens. These
were equally distributed between the groups (receiving a
set change, n = 14; not receiving a change, n = 15). Of the
375 catheters cultured, 10 in the group receiving a set
TABLE 1
DEFINITIONS OF CATHETER-RELATED BACTEREMIA*
Catheter-Related Bacteremia
Probable, Probable,
Finding Definite Type 1 Type 2 Possible
Catheter tip + + + -
Blood culture + + - +
SIRS with defervescence +/- +/- + +
Colonization at other sites - + - -
Infection at other sites - - - -
SIRS = systemic inflammatory response syndrome; + = positive culture result; - = negative or
missing culture result.
*Data from Fraenkel et al.24
TABLE 2
COMPARISON OF THE TWO GROUPS
Group Group Not
Receiving Receiving
a Set a Set
Change Change
(n = 203) (n = 201)
Mean no. of hours in 122.75 (± 26.81) 126.29 (± 29.59)
situ per CVC (± SD)
Male 120 133
Mean age, y (± SD)* 55.06 (± 18.66) 49.78 (± 19.79)
Mean APACHE II  20.11 (± 6.74) 20.22 (± 7.25)
score on admission
(± SD)
Mean APACHE II 17.46 (± 6.78) 17.88 (± 7.29)
score at insertion
(± SD)
Mean no. of ICU-days 6.04 (± 7.67) 6.03 (± 6.47)
at insertion (± SD)
Mean no. of hospital-days 7.95 (± 9.33) 9.84 (± 12.05)
at insertion (± SD)
Site
Subclavian 139 138
Jugular 37 30
Femoral 24 31
Missing 3 2
Mean no. of fluid bag 55.13 (± 28.84) 59.23 (± 31.54)
changes (± SD)
Mean no. of injections 53.74 (± 27.49) 59.69 (± 28.37)
through set (± SD)*
Immunocompromised 7 15
Hypoalbuminemic 64 69
Hyperglycemic 4 3
Propofol transfusion 66 66
TPN transfusion 36 30
Blood transfusion 107 108
Lipid transfusion 36 31
Lumens
Triple 195 192
Quadruple 8 9
CVC inserted by 120 131
registrar
Reason for CVC removal
Routine (day 7) 94 94
Not required 59 62
Suspected CRB 21 16
Patient died 17 15
Malfunction 7 10
Other 5 4
Diagnosis
Medical 66 82
Neurological 51 39
Emergency surgery 37 25
Burns 25 28
Trauma 17 20
Elective surgery 7 7
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change were colonized and 19 in the group not receiving
a change. Colonization per 1,000 catheter-days was 10.4 in
the group receiving a change and 20.1 in the group not
receiving a change. This difference was not significant on
crude analysis (group receiving a set change: odds ratio
[OR], 0.51; 95% confidence interval [CI95], 0.24 to 1.09; P =
.34) or survival analysis (Kaplan–Meier with log-rank
test = 0.87; df = 1; P = .3505) (Fig. 1).
The 29 colonized CVCs belonged to 23 patients. Four
patients had multiple colonized catheters (2 patients with 2
catheters and 2 patients with 3 catheters). Of these, 3
patients had other noncolonized CVCs in the study. Of the
19 patients with a single colonized catheter, 13 had at least 1
other noncolonized CVC. A first-catheter-per-patient analy-
sis (n = 251) was performed and no difference in coloniza-
tion was found between the groups (receiving a set change,
2 colonized; not receiving a change, 8 colonized;
Kaplan–Meier with log-rank test = 2.63; df = 1; P = .1047).
Colonization varied significantly among subclavian
(5.0%), jugular (9.4%), and femoral (20.8%) sites (P = .001).
There were also significant differences in colonization
among patients with neurological (0%), surgical–trauma
(5%), medical (7%), and burns (29%) diagnoses (P < .001).
Catheter-Related Bacteremia
Among the 404 patients, there were 3 cases (1 definite;
1 probable, type 1; and 1 possible) of catheter-related bac-
teremia in the group receiving a set change and 3 (1 probable,
type 1; 1 probable, type 2; and 1 possible) in the group not
receiving a change. Organisms were from the Acinetobacter,
Staphylococcus, Pseudomonas, Enterobacter, and Klebsiella
species. The difference in survival from rates of catheter-relat-
ed bacteremia between the groups was not statistically signif-
icant (Kaplan–Meier with log-rank test, P = .862) (Fig. 2). 
Logistic Regression Model
Bivariate analysis found significant associations
between catheter colonization and the following variables:
age, burns diagnosis, ICU-days on catheter insertion, hos-
pital-days on catheter insertion, Acute Physiology and
Chronic Health Evaluation (APACHE) II score on the day
of insertion, blood transfusion, hypoalbuminemia, sus-
pected catheter-related bacteremia, catheter site, and sub-
sequent catheters in patients with multiple catheters.
These variables were subjected to forward stepwise logis-
tic regression. Only two risk factors entered the multi-
variate model: burns diagnosis (OR, 6.845; CI95, 2.96 to
15.83; P < .001) and increased ICU-days on catheter inser-
tion (OR, 1.080; CI95, 1.035 to 1.127; P < .001).
DISCUSSION 
This study found no statistically significant differ-
ence in the rates of colonization or catheter-related bac-
teremia between catheters with administration sets that
were routinely replaced on day 4 and catheters with
administration sets that were not replaced at all. The
study involved a high-risk population—short-term, anti-
septic-coated CVCs from ICU patients, including those
with severe burns, immunosuppression, parenteral nutri-
tion, and lipid therapy. Survival modeling found no differ-
ence in colonization between the groups when accounting
for the various durations of the implicated catheters. 
The study included catheters in situ for 52 to 196
hours (mean, 124.5 hours), with a significant proportion
(25%) removed on or after catheter-day 7. There were 12
catheters and administration sets that were used longer
than 1 week (168 hours), with 3 of 9 colonized in the
group not receiving a change and 0 of 3 in the group
receiving a set change (no catheter-related bacteremia in
either group). The three longest dwelling CVCs in the
study were all in the group not receiving a change and
were not colonized. Due to the small number of catheters
studied for longer than 1 week, no conclusion can be
drawn about the effect of routine replacement of the
administration set after this point. Until a multicenter, ran-
TABLE 2 (cont’d)
COMPARISON OF THE TWO GROUPS
Group Group Not
Receiving Receiving
a Set a Set
Change Change
(n = 203) (n = 201)
Catheter order number
First 126 125
Second 45 48
Third 21 17
Fourth or more 11 11
CVC = central venous catheter; SD = standard deviation; APACHE = Acute Physiology and
Chronic Health Evaluation; ICU = intensive care unit; TPN = total parenteral nutrition; CRB =
catheter-related bacteremia.
*P < .05.
FIGURE 1. Survival curve for central venous catheters (CVCs) to remain
free of colonization by treatment group.
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domized, controlled trial confirms the study results or
assesses use beyond 1 week, it would be prudent to limit
administration set use to 7 days rather than an unlimited
time frame.
The finding that routine administration set changes
had no effect is congruent with the pathogenesis of colo-
nization in short-term catheters, whereby the skin site is
the dominant route of colonization.21 Skin-site colonization
may occur as early as at catheter insertion (ie, before the
administration sets are even connected)25 and would be
unlikely to be influenced by changes of the distant admin-
istration set. However, administration set replacement
could theoretically influence infective routes involving the
catheter hub or IV fluid. We did not see an effect of set
replacement on semiquantitative catheter colonization;
however, it is possible that had a different culture method
favoring internal luminal culture been used, a different
result may have been found. Traditionally, it has been
assumed that replacement of sets would decrease circuit
contamination. However, it seems equally, if not more, like-
ly that the potential for contamination could be increased
due to the additional manual handling and circuit interrup-
tion, thus providing an opportunity for microorganism
entry.26 Administration set configurations are not static
throughout the catheterization, but are manipulated fre-
quently (to add, remove, or reconfigure infusions, to
replace fluid containers, or to give medications). These
manipulations should involve hand hygiene and set decon-
tamination with 70% alcohol or an iodophor.21,27 In reality,
staff techniques are divergent and may not be aseptic.10
Failure to adhere to rigorous sterile technique on insertion
and at every circuit manipulation would likely override any
benefit of routinely replacing administration sets and may
even encourage poor technique by relying on the proce-
dure to intermittently “resterilize” the circuit. 
The catheters used had a chlorhexidine gluconate
and silver sulfadiazine external coating and have been
shown to be effective at reducing rates of catheter colo-
nization.28 This may have outweighed any effect caused
by administration set replacement. The overall incidences
of colonization and catheter-related bacteremia were low.
A meta-analysis of 12 studies involving identical catheters
reported an average colonization rate of 16.2% (range,
0% to 39.7%)28 compared with our mean of 7.7%.
Administration set replacement may have an effect (posi-
tive or negative) on other catheter populations or in cen-
ters with higher baseline infection rates. However, it is dif-
ficult to imagine that benefits would approach those
achieved by aseptic technique and stringent handwash-
ing. The study included administration sets for parenteral
nutrition, lipid, and propofol infusions, but not blood sets,
which were discarded after use (< 24 hours). Fluid con-
tainers were routinely replaced after a maximum of 24
hours of use to isolate the effect of prolonged use of the
administration set from that of the IV fluid container. It
may be that fluid containers do not require routine
replacement, but this issue was not addressed by the
study.
The study was designed to detect a small29 effect
size of 0.14 on colonization at an alpha of 0.05 with 80%
power. However, the incidences observed were lower
than anticipated (group receiving no set change, 10%;
group receiving a set change, 5%; effect size, 0.09).
Routine set changes may entail a smaller level of risk than
the study was designed to detect. Colonization was a sur-
rogate endpoint for catheter-related bacteremia due to the
statistical difficulties of using the infrequently diagnosed
catheter-related bacteremia. Colonization may not be
associated with deleterious symptoms, although it is to be
avoided due to the potential for colonized catheters to
progress to infection.27,30 Incidence of catheter-related
bacteremia was the clinical phenomenon of interest and
was identical (1.5% of catheters or 3 cases per 1,000
catheter-days) between the groups. This incidence was
lower than that reported in the literature of 5 cases per
1,000 catheter-days.21
There have been many previous studies into the opti-
mal duration of IV administration set use.7-20,31,32 These
studies have been undertaken in a wide variety of patient,
catheter, and infusion populations. Whereas studies have
varied in definitions, endpoints, and size, none has found a
significant difference in catheter colonization or catheter-
related or infusion-related bacteremia between groups with
administration sets used for different times. One study of
parenteral nutrition in neonates found a higher mortality
rate and set fluid contamination in a group using sets for 72
hours compared with a group with a significantly higher
birth weight using sets for 24 hours.14 Previous studies pre-
dominantly examined periods of 72 hours or less and
sought identification of an optimal time point for routine
replacement of the administration set. Our study provides
support for 7-day set use and questions whether routine
changes are necessary at all with the use of a group of
patients who were not subjected to the procedure at any
time during catheterization. 
Recent data on the testing of administration sets for
FIGURE 2. Survival curve for central venous catheters (CVCs) to remain
free of catheter-related bacteremia by treatment group.
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7 days of continuous use found them to remain accurate
and in good physical condition.33 Beyond this time, the
durability of the materials is unknown. From an infection
perspective, this study is the third to evaluate and support
administration set use for 7 days. A randomized, con-
trolled trial in a general ICU reported no difference in the
colonization rates of 332 CVCs with sets replaced at 72 or
168 hours (1 week).32 Another randomized, controlled
trial enrolled 512 oncology patients with sets replaced
within 3 days or between 4 and 7 days of placement.19
Although only a small proportion of sets were used for 7
days, no effect on infusate-related bacteremia was found. 
Routine administration set changes are costly to
perform, at up to $200 (U.S.) per procedure for the equip-
ment alone. Extension of set use to 7 days would result in
significant cost savings, less environmental waste, and the
redirection of nursing time to other patient care, educa-
tion, or research activities. The complex procedure for a
routine administration set change has a ritualistic status
and may be difficult to reduce or disband, particularly
among nurses who value “being busy” as a major theme of
ICU care.34 Staff should be reminded that there is an
absence of supporting evidence for the procedure and a
growing body of evidence suggesting its ineffectiveness.
The evidence-based practice movement seeks to replace
ritualistic and historically based care with treatment that
is scientifically proven to be effective. The results of this
study suggest that evidence-based practice will be
achieved by extending IV administration set use to 7 days
for short-term, antiseptic-coated CVCs. 
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